No title
Background and purpose: Stroke is one of the world’s most common diseases and the second leading cause of death worldwide. From 1996 to 2006 the treatment of acute ischemic stroke (AIS) was limited to intravenous fibrinolytic therapy; a treatment often associated with risk and insufficiency. In 2006, treating AIS by mechanical clot removal, known as thrombectomy, was approved by the U.S. Food and
